The present invention is related to novel compounds of formula (I) having equilibrative nucleoside transporter ENT1 inhibiting properties, pharmaceutical compositions comprising these compounds, chemical processes for preparing these compounds and their use in the treatment of diseases linked to the inhibition of ENT1 receptors in animals, in particular humans.
US8263592B2
申请人:——
公开号:US8263592B2
公开(公告)日:2012-09-11
[EN] EQUILIBRATIVE NUCLEOSIDE TRANSPORTER ENT1 INHIBITORS<br/>[FR] INHIBITEURS DU TRANSPORTEUR ÉQUILIBRANT DES NUCLÉOSIDES ENT1